What is PTC Therapeutics's net change in cash?

PTC Therapeutics (PTCT) reported net change in cash of -$147.9M in Q1 2026.

How has PTC Therapeutics's net change in cash changed year-over-year?

PTC Therapeutics's net change in cash decreased by 121.1% year-over-year, from $700.55M to -$147.9M.

What is the long-term trend for PTC Therapeutics's net change in cash?

Over 2 years (2022 to 2024), PTC Therapeutics's net change in cash has grown at a 36.9% compound annual growth rate (CAGR), from $98.71M to $185.03M.

What does net change in cash mean?

Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.

PTC Therapeutics PTCT Net Change in Cash

Net Change in Cash at other companies

BioMarin PharmaceuticalsBMRN

$1.76B+1,562%

BridgeBio PharmaBBIO

$309.88M+321%

Arrowhead ResearchARWR

-$14.12M-111%

United TherapeuticsUTHR

-$277.4M-237%

BiogenBIIB

$392.2M+108%

ALN

Alnylam PharmaceuticalsALNY

——

Other financials

Income statement

See full

Revenue$272.6M-76.8%

Operating income$45.0M-95.4%

Net income-$2.8M-100%

EPS (diluted)-$0.03-100%

Balance sheet

See full

Cash & equivalents$834.0M-43.7%

Total debt$395.1M+0.1%

Total equity-$180.5M+2.9%

Total assets$2.9B+8.0%

Cash flow

See full

Operating cash flow-$59.0M-107%

CapEx$1.2M-30.6%

Free cash flow-$60.2M-107%

Valuation

See full

Market cap$6.55B+40.3%

Enterprise value$6.11B+77.3%

P/E8×—

P/S7.9×+5.3×

Profitability

See full

Gross margin96%—

Operating margin1.6%-38.7pp

Net margin42.3%+27.4pp

FCF margin39.1%+32.8pp

Returns & leverage

See full

Return on equity-216.7%—

Debt / equity372.3×—

Current ratio2.4×-1.5×

Where this comes from

Reported directly by PTC Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.

The official record: PTC Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about PTC Therapeutics's net change in cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is PTC Therapeutics's net change in cash?: PTC Therapeutics (PTCT) reported net change in cash of -$147.9M in Q1 2026.
How has PTC Therapeutics's net change in cash changed year-over-year?: PTC Therapeutics's net change in cash decreased by 121.1% year-over-year, from $700.55M to -$147.9M.
What is the long-term trend for PTC Therapeutics's net change in cash?: Over 2 years (2022 to 2024), PTC Therapeutics's net change in cash has grown at a 36.9% compound annual growth rate (CAGR), from $98.71M to $185.03M.
What does net change in cash mean?: Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.